I was commenting on Excellagen, the wound treatment product. The question is why have there not been sales for what sounds like a good product. I surmise they wanted to try it out in the VA/military population initially which might hamper the company having revenue figures. Probably gave it to the federal government.
Also, think of Excellagen like the rapidmist platform. It is a delivery system and will have multiple conditions it will have potential efficacy to treat.
Sorry for any confusion.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links